JP2022541178A5 - - Google Patents
Info
- Publication number
- JP2022541178A5 JP2022541178A5 JP2022502246A JP2022502246A JP2022541178A5 JP 2022541178 A5 JP2022541178 A5 JP 2022541178A5 JP 2022502246 A JP2022502246 A JP 2022502246A JP 2022502246 A JP2022502246 A JP 2022502246A JP 2022541178 A5 JP2022541178 A5 JP 2022541178A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- approximately
- picolinamide
- methylpropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201911028435 | 2019-07-15 | ||
| IN201911028435 | 2019-07-15 | ||
| IN202011023329 | 2020-06-03 | ||
| IN202011023329 | 2020-06-03 | ||
| PCT/IB2020/056661 WO2021009695A1 (en) | 2019-07-15 | 2020-07-15 | Formulations of (s)-3-amino-6-methoxy-n-(3,3,3-trifluoro-2-hydroxy-2-methylpropyl)-5-(trifluoromethyl)picolinamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022541178A JP2022541178A (ja) | 2022-09-22 |
| JP2022541178A5 true JP2022541178A5 (https=) | 2023-07-07 |
Family
ID=71738249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022502246A Pending JP2022541178A (ja) | 2019-07-15 | 2020-07-15 | （ｓ）－３－アミノ－６－メトキシ－ｎ－（３，３，３－トリフルオロ－２－ヒドロキシ－２－メチルプロピル）－５－（トリフルオロメチル）ピコリンアミド製剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11865109B2 (https=) |
| EP (1) | EP3999063A1 (https=) |
| JP (1) | JP2022541178A (https=) |
| KR (1) | KR20220035421A (https=) |
| CN (1) | CN114007616A (https=) |
| AU (1) | AU2020313422A1 (https=) |
| BR (1) | BR112022000507A2 (https=) |
| CA (1) | CA3143431A1 (https=) |
| CL (1) | CL2022000079A1 (https=) |
| IL (1) | IL288577A (https=) |
| MX (1) | MX2022000549A (https=) |
| TW (1) | TW202116312A (https=) |
| WO (1) | WO2021009695A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023109939A1 (zh) * | 2021-12-17 | 2023-06-22 | 苏州晶云药物科技股份有限公司 | 吡啶类衍生物的晶型及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8247436B2 (en) | 2010-03-19 | 2012-08-21 | Novartis Ag | Pyridine and pyrazine derivative for the treatment of CF |
| EA029416B1 (ru) * | 2010-06-21 | 2018-03-30 | Заклады Фармацеутицне Польфарма Са | Таблетка, содержащая иматиниб или его фармацевтически приемлемую соль, и способ ее получения |
| ES2952878T3 (es) * | 2016-08-08 | 2023-11-06 | Hetero Labs Ltd | Una composición antirretroviral multiclase |
| AU2017362350B2 (en) | 2016-11-18 | 2021-12-23 | Cystic Fibrosis Foundation | Pyrrolopyrimidines as CFTR potentiators |
| US10131670B2 (en) | 2016-12-16 | 2018-11-20 | Cystic Fibrosis Foundation Therapeutics, Inc. | Bicyclic heteroaryl derivatives as CFTR potentiators |
| US10633341B2 (en) | 2016-12-19 | 2020-04-28 | Novartis Ag | Picolinic acid derivatives and their use as intermediates |
-
2020
- 2020-07-15 BR BR112022000507A patent/BR112022000507A2/pt not_active Application Discontinuation
- 2020-07-15 JP JP2022502246A patent/JP2022541178A/ja active Pending
- 2020-07-15 CA CA3143431A patent/CA3143431A1/en active Pending
- 2020-07-15 TW TW109123960A patent/TW202116312A/zh unknown
- 2020-07-15 AU AU2020313422A patent/AU2020313422A1/en not_active Abandoned
- 2020-07-15 WO PCT/IB2020/056661 patent/WO2021009695A1/en not_active Ceased
- 2020-07-15 CN CN202080047517.XA patent/CN114007616A/zh active Pending
- 2020-07-15 MX MX2022000549A patent/MX2022000549A/es unknown
- 2020-07-15 EP EP20743848.2A patent/EP3999063A1/en not_active Withdrawn
- 2020-07-15 US US16/929,472 patent/US11865109B2/en active Active
- 2020-07-15 KR KR1020227004517A patent/KR20220035421A/ko not_active Withdrawn
-
2021
- 2021-12-01 IL IL288577A patent/IL288577A/en unknown
-
2022
- 2022-01-11 CL CL2022000079A patent/CL2022000079A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7577146B2 (ja) | ルキソリチニブの徐放性投薬形態 | |
| JP6979080B2 (ja) | Ｊａｋ阻害剤を含む医薬組成物 | |
| JP6508544B2 (ja) | 腫瘍を治療するための薬用組成物 | |
| KR102490547B1 (ko) | 퀴놀린 유도체로 갑상선암을 치료하기 위한 방법과 용도 및 갑상선암을 치료하기 위한 약학적 조성물 | |
| JP6825574B2 (ja) | ２−｛４−［ｎ−（５，６−ジフェニルピラジン−２−イル）−ｎ−イソプロピルアミノ］ブチルオキシ｝−ｎ−（メチルスルホニル）アセトアミドを含有する医薬組成物 | |
| JP2017537899A5 (https=) | ||
| JP2022540421A5 (https=) | ||
| CN103764149A (zh) | 新型替卡格雷共晶 | |
| JP6068765B2 (ja) | 薬学的複合製剤 | |
| JP2013518860A (ja) | Ｎ−（２−クロロ−６−メチルフェニル）−２−［［６−［４−（２−ヒドロキシエチル）−１−ピペラジニル］−２−メチル−４−ピリミジニル］アミノ］−５−チアゾールカルボサキミドを含む医薬組成物 | |
| JP2013536243A5 (https=) | ||
| JP2022541178A5 (https=) | ||
| TW201927290A (zh) | 雙層醫藥錠劑調配物 | |
| JP2022532540A (ja) | アキシチニブを含有する医薬組成物 | |
| WO2021080529A1 (en) | Solid pharmaceutical formulations comprising ticagrelor | |
| TWI608849B (zh) | 可調控釋放度之高載藥量之醫藥組合物及其製備方法 | |
| TW200922546A (en) | Galenical formulations of organic compounds | |
| JP2025508402A5 (https=) | ||
| JP2022541178A (ja) | （ｓ）－３－アミノ－６－メトキシ－ｎ－（３，３，３－トリフルオロ－２－ヒドロキシ－２－メチルプロピル）－５－（トリフルオロメチル）ピコリンアミド製剤 | |
| RU2022103412A (ru) | Составы на основе (s)-3-амино-6-метокси-n-(3,3,3-трифтор-2-гидрокси-2-метилпропил)-5-(трифторметил)пиколинамида | |
| WO2019097120A1 (en) | New use and pharmaceutical dosage forms | |
| EA045160B1 (ru) | Фармацевтическая композиция, содержащая акситиниб | |
| JP2023532209A5 (https=) | ||
| HK1231735B (zh) | 喹啉衍生物用於治疗甲状腺癌的方法和用途以及用於治疗甲状腺癌的药物组合物 |